AB

Arie Belldegrun

North America, California, United States, Los Angeles

Description

Arie Belldegrun is the Co-Founder and Chairman of Bellco Capital, a Co-Chairman at Breakthrough Properties, an Executive Chairman and Co-Fou...

Investor Profile

Arie Belldegrun has made 3 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Post Ipo Equity (33%)
  • Debt Financing (33%)
  • Series A (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Therapeutics
  • Biopharma
  • Health Care
  • Oncology
  • Chemical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Arie Belldegrun frequently co-invest with?

Omega Funds
Europe, Geneve, Switzerland, Geneva
Co-Investments: 1
Nextech Invest
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
AC
North America, New York, United States, New York
Co-Investments: 1
BF
North America, Texas, United States, Fort Worth
Co-Investments: 1
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 1
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 1
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 2
Pontifax
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 1
CS
North America, Texas, United States, Dallas
Co-Investments: 1
Invus
North America, New York, United States, New York
Co-Investments: 1

Which angels does Arie Belldegrun often collaborate with?

NB
North America, California, United States, San Mateo
Shared Deals: 1

What are some of recent deals done by Arie Belldegrun?

Kronos Bio

San Mateo, California, United States

Kronos Bio focuses on the research and development of first-in-class therapies that modulate historically recalcitrant cancer.

BiotechnologyChemicalTherapeutics
Series AJul 18, 2019
Amount Raised: $105,000,000
Arno Therapeutics

Parsippany, New Jersey, United States

Arno Therapeutics is a biopharmaceutical company developing innovative products for the treatment of cancer patients.

BiopharmaBiotechnologyMedical
Post Ipo EquityAug 16, 2016
Amount Raised: $8,000,000
Kite Pharma

Los Angeles, California, United States

Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications.

BiotechnologyHealth CareMedicalOncologyTherapeutics
Debt FinancingMay 2, 2014
Amount Raised: $50,000,000